Oncology

SOUTH SAN FRANCISCO, Calif., June 12, 2026 Lyell Immunopharma, Inc. announced updated safety and translational data for rondecabtagene autoleucel...

CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, June 14, 2026 Harbour BioMed has secured a major legal victory in...

SEONGNAM and SEOUL, South Korea, June 15, 2026 Rznomics Inc., a clinical-stage biopharmaceutical company focused on RNA-based gene therapies,...

BOTHELL, Wash., June 11, 2026 Immunome, Inc. announced the first patient has been dosed in a Phase 1 first-in-human...

NORTH CHICAGO, Ill., June 12, 2026 AbbVie announced new long-term clinical results from the Phase 3 CLL14 trial at...

DUBLIN, Ireland, June 12, 2026 Jazz Pharmaceuticals has announced topline results from the Phase 3 LAGOON trial evaluating Zepzelca®...

COPENHAGEN, Denmark, June 11, 2026 Evaxion A/S announced new preclinical data for EVX-04, its off-the-shelf therapeutic cancer vaccine being...

AUSTIN, Texas, June 9, 2026 Zetagen Therapeutics announced preliminary topline results from its Phase 2a clinical study evaluating ZetaMet™...

CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; SHANGHAI, China, June 10, 2026 Harbour BioMed announced that the National Medical Products Administration (NMPA)...

SHANGHAI, China & CAMBRIDGE, Massachusetts, USA – June 9, 2026 Zai Lab has received approval from China’s National Medical...